Twist Bioscience Corp vs GeneDx Holdings Corp — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Twist Bioscience Corp is far larger — about 3× GeneDx Holdings Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| TWST | WGS | |
|---|---|---|
Market Cap | $5.45B | $1.80B |
Sector | Health | Technology |
52-Week High | $102.88 | $167.51 |
52-Week Low | $24.16 | $34.51 |
Enterprise Value | $5.37B | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →